dormicum 7,5 mg apvalkotās tabletes
roche latvija, sia, latvija - midazolāms - apvalkotā tablete - 7,5 mg
swispara 500 mg/12,2 mg pulveris iekšķīgi lietojama šķīduma pagatavošanai
sandoz d.d., slovenia - paracetamolum, phenylephrini hydrochloridum - pulveris iekšķīgi lietojama šķīduma pagatavošanai - 500 mg/12,2 mg
swispara 1000 mg/12,2 mg pulveris iekšķīgi lietojama šķīduma pagatavošanai
sandoz d.d., slovenia - paracetamolum, phenylephrini hydrochloridum - pulveris iekšķīgi lietojama šķīduma pagatavošanai - 1000 mg/12,2 mg
tyruko
sandoz gmbh - natalizumab - multiple sclerosis, relapsing-remitting; multiple sclerosis - imūnsupresanti - tyruko is indicated as single disease modifying therapy in adults with highly active relapsing remitting multiple sclerosis (rrms) for the following patient groups: patients with highly active disease despite a full and adequate course of treatment with at least one disease modifying therapy (dmt) (for exceptions and information about washout periods see sections 4. 4 un 5. 1), or, patients with rapidly evolving severe rrms defined by 2 or more disabling relapses in one year, and with 1 or more gadolinium enhancing lesions on brain magnetic resonance imaging (mri) or a significant increase in t2 lesion load as compared to a previous recent mri.
ciclosporin sandoz 25 mg mīkstās kapsulas
sandoz d.d., slovenia - ciklosporīns - kapsula, mīkstā - 25 mg
ciclosporin sandoz 50 mg mīkstās kapsulas
sandoz d.d., slovenia - ciklosporīns - kapsula, mīkstā - 50 mg
ciclosporin sandoz 100 mg mīkstās kapsulas
sandoz d.d., slovenia - ciklosporīns - kapsula, mīkstā - 100 mg
ηtribu-vit500, ηgokshura500 (paziņots 2011.) kapsula
es pēc "dion sportlab" sia pasūtījuma - kapsula
kapruvia
vifor fresenius medical care renal pharma france - difelikefalin - pruritus - visi pārējie terapeitiskie produkti - kapruvia is indicated for the treatment of moderate-to-severe pruritus associated with chronic kidney disease in adult patients on haemodialysis (see section 5.